Her position is funded in part by the Translational Data Analytics at OSU initiative. Her primary research interest are to leverage epigenomics, genomics, nucleotide variants and metabolic patterns to 1) understand how the genetic and epigenetic landscape affects disease phenotypes, particularly cancer; 2) define cell-type and disease-type specific molecular characteristics to uncover novel biomarkers and guide the search of novel therapeutic targets.